| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |